A facile synthesis of precursor for the σ-1 receptor PET radioligand [18 F]FTC-146 and its radiofluorination

J Labelled Comp Radiopharm. 2024 Feb;67(2):59-66. doi: 10.1002/jlcr.4081. Epub 2024 Jan 3.

Abstract

The σ-1 receptor is a non-opioid transmembrane protein involved in various human pathologies including neurodegenerative diseases, inflammation, and cancer. The previously published ligand [18 F]FTC-146 is among the most promising tools for σ-1 molecular imaging by positron emission tomography (PET), with a potential for application in clinical diagnostics and research. However, the published six- or four-step synthesis of the tosyl ester precursor for its radiosynthesis is complicated and time-consuming. Herein, we present a simple one-step precursor synthesis followed by a one-step fluorine-18 labeling procedure that streamlines the preparation of [18 F]FTC-146. Instead of a tosyl-based precursor, we developed a one-step synthesis of the precursor analog AM-16 containing a chloride leaving group for the SN 2 reaction with 18 F-fluoride. 18 F-fluorination of AM-16 led to a moderate decay-corrected radiochemical yield (RCY = 7.5%) with molar activity (Am ) of 45.9 GBq/μmol. Further optimization of this procedure should enable routine radiopharmaceutical production of this promising PET tracer.

Keywords: FTC-146; PET; [18F]FTC-146; chloride leaving group, fluorine-18; non-activated; precursor; radiopharmaceutical; radiosynthesis; σ-1 receptor.

MeSH terms

  • Azepines
  • Benzothiazoles
  • Fluorine Radioisotopes / chemistry
  • Humans
  • Positron-Emission Tomography* / methods
  • Radiopharmaceuticals
  • Sigma-1 Receptor*

Substances

  • Sigma-1 Receptor
  • 6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-one
  • Fluorine Radioisotopes
  • Azepines
  • Benzothiazoles
  • Radiopharmaceuticals